Table 2.
Comparison of adherence to quality indicators in the pre- and post-intervention cohorts
| Quality indicator | Adherence pre-intervention N = 49 | Adherence post-intervention N = 37 | P-value |
|---|---|---|---|
| Clostridioides difficile toxin testing | 37 (75.5%) | 34 (91.9%) | <0.05 |
| Stool culture performed | 37 (75.5%) | 31 (83.8%) | 0.35 |
| Abdominal X-ray performed | 19 (38.8%) | 15 (42.9%) | 0.71 |
| Flexible sigmoidoscopy within 72 h of presentation | 16 (32.7%) | 13 (35.1%) | 0.81 |
| C-reactive protein performed within 24 h of presentation | 35 (71.4%) | 35 (94.6%) | <0.01 |
| Testing for latent tuberculosis performed or previously documented | 16 (38.1%) | 22 (84.6%) | <0.01 |
| Venous thromboembolism prophylaxis initiated within 24 h of presentation | 14 (28.6%) | 32 (86.5%) | <0.01 |
| Intravenous steroids at a dose-equivalent of 60 mg of solumedrol in total | 35 (72.9%) | 35 (94.6%) | <0.01 |
| Infliximab given after 5 days of corticosteroids, intravenous route, with proper dosage | 5/15 (33.3%) | 5/14 (35.7%) | 1.00 |
| Narcotics prescribed | 33 (68.8%) | 14 (38.9%) | <0.01 |
| Surgery consultation after 5–7 days of therapy | 3/3 (100.0%) | 3/3 (100.0%) | 1.00 |